ZENPEP- pancrelipase lipase, pancrelipase protease, pancrelipase amylase capsule, delayed release Verenigde Staten - Engels - NLM (National Library of Medicine)

zenpep- pancrelipase lipase, pancrelipase protease, pancrelipase amylase capsule, delayed release

allergan, inc. - pancrelipase lipase (unii: 8myc33932o) (pancrelipase lipase - unii:8myc33932o), pancrelipase protease (unii: 3560d81v50) (pancrelipase protease - unii:3560d81v50), pancrelipase amylase (unii: yoj58o116e) (pancrelipase amylase - unii:yoj58o116e) - pancrelipase lipase 3000 [usp'u] - zenpep® is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. none. risk summary published data from case reports with pancrelipase use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. pancrelipase is minimally absorbed systematically; therefore, maternal use is not expected to result in fetal exposure to the drug. animal reproduction studies have not been conducted with pancrelipase. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary there are no data on the presence of pancrelipase in either human or animal milk, the effects

GANFORT PF Eye Drops Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ganfort pf eye drops

allergan malaysia sdn bhd - bimatoprost; timolol maleate -

ZYMAR 0.3% EYE DROPS Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zymar 0.3% eye drops

allergan malaysia sdn bhd - gatifloxacin -

ALPHAGAN P Ophthalmic Solution 0.1% Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

alphagan p ophthalmic solution 0.1%

allergan malaysia sdn bhd - brimonidine tartrate -

LATISSE (bimatoprost ophthalmic solution) 0.03% Singapore - Engels - HSA (Health Sciences Authority)

latisse (bimatoprost ophthalmic solution) 0.03%

allergan singapore pte. ltd. - bimatoprost - solution, sterile - 0.3mg/ml

FML LIQUIFILM STERILE OPHTHALMIC S* Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fml liquifilm sterile ophthalmic s*

allergan malaysia sdn bhd - fluorometholone -

VALLERGAN Tablets 10 Milligram Ierland - Engels - HPRA (Health Products Regulatory Authority)

vallergan tablets 10 milligram

sanofi-aventis ireland limited - trimeprazine tartare - tablets - 10 milligram

VALLERGAN 10 Milligram Tablets Ierland - Engels - HPRA (Health Products Regulatory Authority)

vallergan 10 milligram tablets

sanofi-aventis ireland limited t/a sanofi - trimeprazine tartare - tablets - 10 milligram

Ganfort Europese Unie - Engels - EMA (European Medicines Agency)

ganfort

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Enzepi Europese Unie - Engels - EMA (European Medicines Agency)

enzepi

allergan pharmaceuticals international ltd - pancreas powder - exocrine pancreatic insufficiency - digestives, incl. enzymes - pancreatic enzyme replacement treatment in exocrine pancreatic insufficiency due to cystic fibrosis or other conditions (e.g. chronic pancreatitis, post pancreatectomy or pancreatic cancer).enzepi is indicated in infants, children, adolescents and adults.